VCRE - Vicore Pharma Holding AB American Depositary Shares | Scanr.ai
VCRE
Vicore Pharma Holding AB American Depositary Shares
XNAS
11.28
0.22
1.99%
Jul 28, 11:03 AM EDT
Enlarge chart
Fullscreen chart
O 11.38H 11.38L 11.28C 11.28Vol 1.83K
Jul 28, 2026
Vicore Pharma Holding AB American Depositary Shares
Vicore Pharma Holding AB is a clinical-stage biopharmaceutical company developing a new class of disease-modifying therapies for respiratory and fibrotic diseases,including idiopathic pulmonary fibrosis (IPF). Its main program, buloxibutid, is an oral angiotensin II type 2 receptor agonist that has received Orphan Drug and Fast Track designation from the U.S. Food and Drug Administration and is currently being evaluated in the 52-week Phase 2b ASPIRE trial in IPF. Currently, Vicore is operating mainly in Sweden.
